Clinical Trial Update: Human Intestinal Peptides Evaluation and Research

View source ↗

Summary

A clinical trial update evaluating human intestinal peptides for obesity and type 2 diabetes, with the current status not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Turkish Metabolic Surgery Foundation | Conditions: Obesity, Diabetes Mellitus, Type 2 | Status: UNKNOWN